Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9688692
Neprilysin inhibitors
granted -
US 9688710
Inhibitors of sodium glucose cotransporter 1
granted -
US 9688637
3-amidobenzamides and uses thereof for increasing cellular levels of A3G and other A3 family members
granted -
US 9688673
Deoxycytidine kinase binding compounds
granted -
US 9688638
Opioid agonists and uses thereof
granted -
US 9687550
Compositions for nucleic acid delivery
granted -
US 9687553
Polymeric nanocarriers with linear dual response mechanism
granted -
US 9687532
Sialylated glycoprotein compositons and uses thereof
granted -
US 9687527
Stable glucagon formulations for the treatment of hypoglycemia
granted -
US 9687522
Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
granted -
US 9687566
Low affinity FCGR deficient mice
granted -
US 9687461
Method for detecting risk factor for metabolic syndrome or hyperferritinemia
granted -
US 9687454
Sublingual and buccal film compositions
granted -
US 9687448
Nucleic acid lipid particle formulations
granted -
US 9687559
Heparosan polymers and methods of making and using same for the enhancement of therapeutics
granted -
US 9687450
Oxidized cellulose microspheres
granted -
US 9689042
Use of glycolytic pathways for inhibiting or measuring oncogenic signaling
granted -
US 2017174672
FUSED (HETERO)CYCLIC COMPOUNDS AS S1P MODULATORS
granted -
US 9682969
Phthalazinone compounds and methods for the treatment of cystic fibrosis
granted -
US 9682033
Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
granted -
US 9682107
Postnatal stem cells and uses thereof
granted -
US 9682151
Peptides whose uptake in cells is controllable
granted -
US 9682957
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
granted -
US 9683002
Neprilysin inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.